Fact CheckerSign in

NCT04184479Recruiting

Effect of the LEVAmethod by Bertz et al © in Subjects With Overweight or Obesity in Primary Health Care.

Placebo-Controlled, Randomized Weight Loss InterventionTrial in Subjects With Overweight or Obesity in Primary Health Care

Source: ClinicalTrials.gov · Last updated 25 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study evaluates weight loss effect of the method LEVA by Bertz et al in subjects with overweight or obesity that are remitted to Primärvårdens Dietistenhet.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
200 (estimated)
First submitted
24 Nov 2019
Start date
2 Dec 2020
Primary completion date
Aug 2026
Lead sponsor
Vastra Gotaland Region
Diseases
Obesity
NCT number
NCT04184479

What you commit to

  • Study type: Interventional
  • Planned participants: 200
  • From 2 Dec 2020 to the primary completion date, Aug 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • difficulty understanding Swedish, spoken or read
  • does not manage/want to handle digital Tools
  • the remittance was addressed to Primärvårdens Dietistenhet at wrong premises and the patient should be treated elsewhere.

Who the study is looking for

  • BMI 27 ≤ 35
  • age 18-75 år

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Västra Götalandsregionen
Coordinator of this site? Confirm its status
GothenburgSwedenRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.